The EARL study is aimed at identifying and implementing solutions to key structural (ethical, administrative, regulatory and logistical) bottlenecks as well as behavioural and cultural (BC) barriers to the rapid implementation of large multi-site clinical studies in Europe in response to severe ID outbreaks.
Quick Reference Documents
Barriers and Solutions table
Clinical Trials Regulation update
Data Protection Regulations (coming soon)
Quick reference of consent models including definitions and legislation governing their use (coming soon)
Country information regarding expedited review processes and pre-approved protocols
All EARL reports are available in the PREPARE Member Area